Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

BIBF 1120 in Recurrent Glioblastoma Multiforme

This study has been completed.
Boehringer Ingelheim
University of Copenhagen
Information provided by (Responsible Party):
Ulrik Lassen, Rigshospitalet, Denmark Identifier:
First received: December 1, 2010
Last updated: October 3, 2012
Last verified: October 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2012
  Primary Completion Date: August 2012 (Final data collection date for primary outcome measure)